Clinical Study Results
The researchers did not think either of these serious adverse events were related
to the study drug.
None of the participants died during the study.
Adverse events
There were 32.8% of participants who had adverse events during the study. This
was 21 out of 64 participants.
The table below shows how many participants had adverse events during the study.
Adverse events during the study
30 mg 100 mg 300 mg 600 mg
MEDI5884 MEDI5884 MEDI5884 MEDI5884 Placebo
(out of 12 (out of 12 (out of 12 (out of 12 (out of 16
participants) participants) participants) participants) participants)
How many
participants
had adverse 41.7% (5) 33.3% (4) 16.7% (2) 41.7% (5) 31.3% (5)
events during
the study?
How many
participants
had serious
0.0% (0) 0.0% (0) 0.0% (0) 8.3% (1) 0.0% (0)
adverse events
during the
study?
How many
participants
stopped
0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
treatment due
to adverse
events?
7